Kiromic Biopharma Inc (KRBP) — Net Asset Quality Index
Kiromic Biopharma Inc (KRBP) has a Net Asset Quality Index of -147.3% as of December 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $8.54 Million minus total liabilities of $21.13 Million yields net assets of $-12.59 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Kiromic Biopharma Inc total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Kiromic Biopharma Inc Net Asset Quality Index Over Time (2018–2024)
This chart shows how Kiromic Biopharma Inc's Net Asset Quality Index has evolved across 7 annual periods from 2018 to 2024. As of December 2024, the index stands at -147.3%, representing net assets of $-12.59 Million against total assets of $8.54 Million USD. For live market cap and overall valuation, see KRBP market cap.
Annual Net Asset Quality Index for Kiromic Biopharma Inc (2018–2024)
The table below presents the year-by-year Net Asset Quality Index for Kiromic Biopharma Inc from 2018 to 2024, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Kiromic Biopharma Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -147.3% | $-12.59 Million | $8.54 Million | $21.13 Million | ▼ -72.4 pp |
| 2023 | -75.0% | $-9.12 Million | $12.17 Million | $21.29 Million | ▼ -26.7 pp |
| 2022 | -48.3% | $-5.77 Million | $11.97 Million | $17.74 Million | ▼ -137.2 pp |
| 2021 | 88.9% | $27.32 Million | $30.73 Million | $3.41 Million | ▲ +0.3 pp |
| 2020 | 88.6% | $11.36 Million | $12.83 Million | $1.47 Million | ▲ +14.0 pp |
| 2019 | 74.6% | $1.98 Million | $2.65 Million | $673.70K | ▲ +44.3 pp |
| 2018 | 30.3% | $265.30K | $876.00K | $610.70K | — |